86 results
8-K
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
limitation statements regarding the potential, safety, efficacy, and regulatory and clinical progress of, and our business strategy and plans for, our
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
, initiated, conducted or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, “dear doctor … ” letter or other notice or action relating to the alleged lack of safety or efficacy of any product or any alleged product defect or violation
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
for information on reporting suspected adverse reactions in Europe.
Please see the full Prescribing Information for additional Important Safety Information … , including without limitation statements regarding the potential, safety, efficacy, and regulatory and clinical progress of, and our business strategy
8-K
EX-99.1
9gpn8f4h
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
xl70jfc
4 Jan 24
Entry into a Material Definitive Agreement
7:00am
8-K
pmh du3rmp3
6 Dec 23
Other Events
4:30pm
8-K
EX-99.1
vo040
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
gsv8z0y 1sfkp
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
ixz964sdsay9xdv6kiqw
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
eu5v9 bx5t5p30fy1mc
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
8-K
EX-1.1
y1ral2rl
15 Sep 22
Other Events
4:02pm